Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Cervical Cancer
Drug:
capecitabine
(
Thymidylate synthase inhibitor
) +
mitomycin
(
DNA synthesis inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
09/20/2023
Excerpt:
Cervical Cancer: SYSTEMIC THERAPY FOR CERVICAL CANCER…Other Recommended Regimens…Capecitabine/mitomycin…
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login